{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:29:10Z","timestamp":1794832150186,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biomaterials.2024.122997","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T02:55:32Z","timestamp":1733453732000},"page":"122997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Mesoporous polydopamine nanoparticle-based tolerogenic vaccine induces antigen-specific immune tolerance to prevent and treat autoimmune multiple sclerosis"],"prefix":"10.1016","volume":"316","author":[{"given":"Ngoc Man","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Loc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4243-4604","authenticated-orcid":false,"given":"Dong Kwang","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4687-6732","authenticated-orcid":false,"given":"Jaeyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biomaterials.2024.122997_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122997_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122997_bib3","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological Phenotypes1","volume":"183","author":"J\u00e4ger","year":"2009","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122997_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"7591","key":"10.1016\/j.biomaterials.2024.122997_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122997_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122997_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122997_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122997_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2017.00532","article-title":"Peripherally induced regulatory T cells: recruited protectors of the central nervous system against autoimmune neuroinflammation","volume":"8","author":"Jones","year":"2017","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122997_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat. Immunol."},{"issue":"7591","key":"10.1016\/j.biomaterials.2024.122997_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122997_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.3071","article-title":"Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy","volume":"33","author":"Kim","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122997_bib13","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1021\/acsnano.0c04188","article-title":"Enhanced cancer DNA vaccine via direct transfection to host dendritic cells recruited in injectable scaffolds","volume":"14","author":"Nguyen","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2024.122997_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119859","article-title":"Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen\/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold","volume":"239","author":"Nguyen","year":"2020","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122997_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/acscentsci.8b00035","article-title":"Extra-large pore mesoporous silica nanoparticles enabling Co-delivery of high amounts of protein antigen and toll-like receptor 9 agonist for enhanced cancer vaccine efficacy","volume":"4","author":"Cha","year":"2018","journal-title":"ACS Cent. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122997_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrneurol.2010.112","article-title":"Targeting dendritic cells to treat multiple sclerosis","volume":"6","author":"Comabella","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"16","key":"10.1016\/j.biomaterials.2024.122997_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168415","article-title":"Tolerogenic dendritic cell-based approaches in autoimmunity","volume":"22","author":"Passeri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122997_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","article-title":"Tolerogenic dendritic cells in autoimmunity and inflammatory diseases","volume":"42","author":"Morante-Palacios","year":"2021","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122997_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1471-4906(01)01952-4","article-title":"Dendritic cells as a tool to induce anergic and regulatory T cells","volume":"22","author":"Jonuleit","year":"2001","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122997_bib20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nri3477","article-title":"The role of dendritic cells in autoimmunity","volume":"13","author":"Ganguly","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122997_bib21","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3389\/fimmu.2017.01764","article-title":"Tolerance through education: how tolerogenic dendritic cells shape immunity","volume":"8","author":"Domogalla","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122997_bib22","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.4049\/jimmunol.171.6.3010","article-title":"Generation and function of reactive oxygen species in dendritic cells during antigen presentation","volume":"171","author":"Matsue","year":"1950","journal-title":"Journal of immunology (Baltimore, Md"},{"key":"10.1016\/j.biomaterials.2024.122997_bib23","article-title":"Reactive oxygen species in autoimmune cells: function","volume":"12","author":"Lin","year":"2021","journal-title":"Differentiation, and Metabolism"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122997_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1440-1711.2005.01323.x","article-title":"Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells","volume":"83","author":"Maemura","year":"2005","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122997_bib25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1089\/ars.2012.4557","article-title":"Reactive oxygen species production in the phagosome: impact on antigen presentation in dendritic cells","volume":"18","author":"Kotsias","year":"2013","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122997_bib26","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1038\/s41467-022-35263-9","article-title":"Immunosuppressive biomaterial-based therapeutic vaccine to treat multiple sclerosis via re-establishing immune tolerance","volume":"13","author":"Nguyen","year":"2022","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.biomaterials.2024.122997_bib27","doi-asserted-by":"crossref","first-page":"24696","DOI":"10.1021\/acsnano.3c04497","article-title":"ROS-scavenging lignin-based tolerogenic nanoparticle vaccine for treatment of multiple sclerosis","volume":"17","author":"Phan","year":"2023","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.biomaterials.2024.122997_bib28","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1039\/D0BM01070G","article-title":"Polydopamine free radical scavengers","volume":"8","author":"Hu","year":"2020","journal-title":"Biomater. Sci."},{"issue":"86","key":"10.1016\/j.biomaterials.2024.122997_bib29","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice","author":"Au - Bittner","year":"2014","journal-title":"JoVE"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122997_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s001090050092","article-title":"Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis","volume":"75","author":"Bernard","year":"1997","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122997_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12951-021-01109-7","article-title":"Dye-loaded mesoporous polydopamine nanoparticles for multimodal tumor theranostics with enhanced immunogenic cell death","volume":"19","author":"Tian","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2024.122997_bib32","first-page":"99","article-title":"Polyphenol compounds as antioxidants for disease prevention: reactive oxygen species scavenging, enzyme regulation, and metal chelation mechanisms in E. coli and human cells, oxidative stress","author":"Wang","year":"2011","journal-title":"Diagnostics, Prevention, and Therapy"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122997_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1360-1385(97)01018-2","article-title":"Antioxidant properties of phenolic compounds","volume":"2","author":"Rice-Evans","year":"1997","journal-title":"Trends Plant Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122997_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0b013e328329e31c","article-title":"Early lipopolysaccharide-induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells","volume":"27","author":"Simon","year":"2009","journal-title":"J. Hypertens."},{"issue":"25","key":"10.1016\/j.biomaterials.2024.122997_bib35","doi-asserted-by":"crossref","first-page":"22131","DOI":"10.1074\/jbc.M111883200","article-title":"Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression","volume":"277","author":"Hsu","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122997_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122997_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122997_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2008.08.035","article-title":"Elevated myeloperoxidase activity in white matter in multiple sclerosis","volume":"444","author":"Gray","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122997_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/acschemneuro.7b00462","article-title":"Myeloperoxidase and neurological disorder: a crosstalk","volume":"9","author":"Pravalika","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biomaterials.2024.122997_bib40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2015.00604","article-title":"Involvement of CD8(+) T cells in multiple sclerosis","volume":"6","author":"Salou","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122997_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fimmu.2012.00064","article-title":"Pathogenic CD8 T cells in multiple sclerosis and its experimental models","volume":"3","author":"Huseby","year":"2012","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122997_bib42","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41419-021-04310-6","article-title":"CD8+ T cells specific for cryptic apoptosis-associated epitopes exacerbate experimental autoimmune encephalomyelitis","volume":"12","author":"Feizi","year":"2021","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122997_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11091728","article-title":"Oxidative DNA damage in the pathophysiology of spinal cord injury: seems obvious, but where is the evidence?","volume":"11","author":"Scheijen","year":"2022","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122997_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sc.2011.111","article-title":"Oxidative stress in spinal cord injury and antioxidant-based intervention","volume":"50","author":"Jia","year":"2012","journal-title":"Spinal Cord"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224005337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224005337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T04:00:51Z","timestamp":1735272051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224005337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"alternative-id":["S0142961224005337"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122997","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesoporous polydopamine nanoparticle-based tolerogenic vaccine induces antigen-specific immune tolerance to prevent and treat autoimmune multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122997"}}